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Abstract: Sympathetic hyperactivation is one of the causes of post-
operative ileus, which occurs frequently after abdominal surgery and
adversely influences the patient’s prognosis. We aimed to investigate
whether dexmedetomidine (DEX) could attenuate postoperative ileus in
patients undergoing laparoscopic gastrectomy.
Ninety-two patients were randomized to the control (n¼ 46) or DEX
group (n¼ 46). DEXwas administered at a loading dose of 0.5mg/kg for
10minutes, followed by an infusion rate of 0.4mg/kg/h from insufflation
of the pneumoperitoneum to the end of surgery. The primary goal was to
compare postoperative bowel movements by evaluating the time to first
flatus. The balance of the autonomic nervous system, duration of
postoperative hospital stay, and pain scores were assessed.
The time to first flatus was shorter in the DEX group compared with
the control group (67.2 16.8 hours vs 79.9 15.9 hours, P< 0.001).
The low-frequency/high-frequency power ratio during pneumoperito-
neum increased in the control group, compared with baseline values and
the DEX group. The length of postoperative hospital stay was shorter in
the DEX group compared with the control group (5.4 0.7 days vs
5.8 1.1 days, P¼ 0.04). Patients in the DEX group had lower pain
scores and required fewer analgesics at 1 hour postoperatively.
DEX facilitated bowel movements and reduced the length of hospital
stay in patients undergoing laparoscopic gastrectomy. This may be
attributed to the sympatholytic and opioid-sparing effects of DEX.
(Medicine 94(24):e959)
Abbreviations: ANS = autonomic nervous system, BIS =
bispectral index, EKG = electrocardiography, ETCO2 = end-tidal
CO2, HF = high frequency, HR = heart rate, HRV = heart rate
variability, LF = low frequency, MBP = mean blood pressure, NRSYoung Lee, MD, P n, MD, PhD, Sun
D, and Young Chul Yoo, MD, PhD
INTRODUCTION
P ostoperative ileus is a frequently occurring complicationafter abdominal surgery. It presents as the lack of flatus and
defecation, along with the inability to tolerate enteral nutrition.
Although the cessation of bowel movement and delayed gastric
emptying can last for a maximum of 5 days after abdominal
surgery, prolonged ileus may result in increased morbidity and
longer hospital stays, thus increasing hospital costs.1,2
Surgical trauma and the direct manipulation of intestines
are the most important factors in the occurrence of postopera-
tive ileus.3 In comparison with open surgeries, minimally
invasive techniques, such as laparoscopy, can significantly
minimize trauma and inflammation in the gastrointestinal tract,
thus resulting in less pain and shorter durations of postoperative
ileus and hospital stay.4 Despite these advantages of laparo-
scopic surgery, pneumoperitoneum, which is required for ade-
quate visualization during laparoscopic surgery, has been
reported to induce sympathetic activation and catecholamine
release.5 Patients undergoing laparoscopic surgery with pneu-
moperitoneum showed larger hemodynamic changes and sym-
pathetic hyperactivation compared with those undergoing
laparoscopic surgery with the abdominal wall-lifting method.6
Sympathetic hyperactivity is an important factor in the
development of postoperative bowel atonia. The administration
of a sympatholytic agent or epidural blockade has been reported
to stimulate depressed gut motility and shorten the time to first
flatus after abdominal surgery.7,8 Dexmedetomidine (DEX) is a
highly selective a2 adrenoceptor agonist that possesses hypno-
tic, sedative, and sympatholytic properties without respiratory
depression.9 Its sympatholytic effect maintains hemodynamic
stability by reducing norepinephrine release.10
We hypothesized that DEX could attenuate sympathetic
hyperactivation during laparoscopic surgery and decrease post-
operative ileus. The aim of this study was to investigate the effect
of intraoperative DEX administration on postoperative bowel
movements in patients undergoing laparoscopic gastrectomy.
METHODS
This randomized, double blind, placebo-controlled study
was approved by the institutional review board and hospital
research ethics committee of Severance Hospital at the Yonsei
University Health System in Seoul, South Korea, on May 26,
2014 (No. 4-2014-0249). This study was registered at www.
clinicaltrials.gov on June 9, 2014 (NCT02164448). Written
consent was obtained from all of the patients. Patientso were scheduled for laparoscopic gas-
hysical status classification of I to III of
of Anesthesiologists were included.
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Patients were excluded if they met at least one of the following
criteria: heart block greater than the first degree, bradycardia
(heart rate [HR]< 60 bpm), clinically significant cardiovascu-
lar, renal, or hepatic diseases, and an allergy to a2 adrenergic
agonists.
Enrolled patients were randomly assigned to either the
control or the DEX group in a 1:1 ratio by using a computer-
generated random number table. Assignments were concealed
in sealed envelopes. The randomization was not stratified or
blocked. The study drugs were prepared in identical 50-mL
syringes by an anesthesia nurse who was blinded to the group
assignment. DEX 200mg was added to saline to achieve a total
volume of 50 mL, resulting in a concentration of 4mg/mL. The
DEX group received the DEX infusion at a rate of 0.4mg/kg/h
after a loading dose of 0.5mg/kg for 10 minutes. The control
group received saline instead of DEX. The infusion was started
after insufflation of the pneumoperitoneum and continued until
the end of surgery. The surgeon, patients, attending anesthe-
siologists, operating room (OR) nurses, recovery nurses, and
ward nurses were blinded to the group assignment.
In the OR, patients were premedicated with glycopyrrolate
0.2 mg to reduce oral secretion. Each patient was monitored using
electrocardiography (EKG), pulse oximetry, noninvasive blood
pressure measurements, and capnography. Oxygen saturation,
HR, and mean blood pressure (MBP) were recorded every
5 minutes. After obtaining a baseline measurement of HR and
MBP, anesthesia was induced with propofol 1.5 to 2.5 mg/kg and
remifentanil 1mg/kg. Following the loss of consciousness, rocur-
onium 0.6 mg/kg was administered to facilitate tracheal intuba-
tion. After induction, end-tidal desflurane concentrations were
maintained at 4 to 6 vol%, and remifentanil was infused at a rate
of 0.05 to 0.1mg/kg/min. The anesthetic agents were titrated to
maintain MBP and HR within 25% of baseline values and to
provide adequate depth of anesthesia. Anesthetic depth was
monitored using a bispectral index (BIS) monitor (Aspect
A-2000; Aspect Medical System Inc, Newton, MA), and BIS
scores were maintained in the range of 40 to 60. Controlled
ventilation was performed with an oxygen–air mixture (FiO2 0.4)
to maintain end-tidal CO2 (ETCO2) at 35 to 40 mm Hg, and a
positive end-expiratory pressure of 5 cm H2O was applied to all
patients. Body temperature was maintained at 36 to 37 8C using a
forced air warming system. Pneumoperitoneum was induced by
insufflation of CO2, and the intra-abdominal pressure was main-
tained at 12 to 15 mm Hg. When the laparoscope was withdrawn,
ramosetron 0.3 mg was intravenously given to prevent post-
operative nausea and vomiting. The residual neuromuscular
block was reversed with neostigmine 40mg/kg and glycopyrro-
late 5mg/kg. For postoperative pain control, a patient-controlled
analgesia (PCA) delivery system was started from 30 minutes
before the end of surgery. The PCA system was programmed
to deliver fentanyl with a basal infusion rate of 0.3mg/kg/h
and 0.15-mg/kg boluses on demand with a lockout interval of
15 minutes. After emergence from anesthesia, patients were
intravenously given fentanyl 50mg/kg to control acute pain.
The primary goal of this study was to evaluate the effect of
intraoperative DEX infusion on postoperative bowel move-
ments. The recovery of bowel function was evaluated by time
to first flatus and time to first diet intake. The secondary
outcomes were hemodynamic variables, heart rate variability
(HRV; measure of the balance of the autonomic nervous system
[ANS]), postoperative pain scores, duration of postoperative
Cho et alhospital stay, and complications.
Hemodynamic values were collected at baseline (T0),
10 minutes after induction and intubation (T1), 10 minutes
2 | www.md-journal.comafter CO2 insufflation (T2), 1 hour after CO2 insufflation (T3), 2
hours after CO2 insufflation (T4), and 10 minutes after CO2
desufflation (T5). To evaluate ANS balance, a standard, real-
time, automated, 3-lead EKG was continuously recorded with a
data acquisition system to analyze HRV. The spectral analysis of
HRV is widely used as a noninvasive method to assess cardiac
sympathetic and parasympathetic nervous system functions,
which are measured as fluctuations in R–R intervals on
EKGs.11 HRV was analyzed using LabChart Pro version 7 with
HRV modules (ADInstruments, Co., Sydney, Australia). Five-
minute segments of data without ectopic beats or artifacts were
analyzed from T1 to T5. Frequency-domain HRV indices were
obtained with power spectral density analyses by the fast
Fourier transformation. Two major power spectrum components
were obtained: high-frequency (HF 0.15–0.4 Hz) power and
low-frequency (LF 0.04–0.15 Hz) power. HF power represented
parasympathetic nervous system activity, whereas LF power
represented both sympathetic and parasympathetic nervous
system activities. The ratio of LF/HF power was calculated
to evaluate ANS balance. Pain scores were assessed using a
numerical rating scale (NRS, 0¼ no pain to 10¼worst pain) at
postoperative 30 minutes, 6 hours, 24 hours, and 48 hours.
Patients reporting an NRS pain score >4 at 2 consecutive
evaluations were administered fentanyl 50mg or pethidine
25 mg. Pethidine was given if shivering was also present in
the postanesthesia care unit (PACU). Additional pethidine was
available to both groups for breakthrough pain in the ward.
Statistical Analysis
The sample size was calculated based on results that were
previously published in patients undergoing laparoscopic gas-
trectomy. The average time to the return of bowel movement
was 3.3 0.7 days.12 We estimated that 42 patients in each
group would be required to detect a reduction of 0.5 days with
90% power at a significance of P< 0.05. We factored in a 10%
dropout rate and enrolled 46 patients in each group.
Statistical analyses were performed with IBM SPSS 20.0
(IBM Corp, Armonk, NY) and SAS 9.2 (SAS Institute Inc, Cary,
NC). Data are shown as the number of subjects, mean stan-
standard deviation, or mean standard deviation of the mean.
Comparisons between groups were performed using the x2 test
for categorical variables. Variables with repeated measures,
such as MBP and HR, were analyzed using a linear mixed
model with patient indicator as a random effect and group, time,
and group-by-time as fixed effects. The group-by-time inter-
action assesses whether the change over time differs between
groups. Between-group comparisons of continuous variables
other than those previously mentioned were performed by the
Student 2-sample t test. Post hoc analyses with the Bonferroni
correction were performed for multiple comparisons when
variables with repeated measures showed significant differences
between groups. HRV data were tested for the normality of
distribution with the Kolmogorov–Smirnov test, and data with
nonnormal distributions were analyzed by the Mann–Whitney
U test with P values that were adjusted by the Bonferroni
correction (P< 0.05) for multiple comparisons among groups.
A P value <0.05 was considered statistically significant.
RESULTS
Ninety-two patients were initially enrolled in this study
Medicine  Volume 94, Number 24, June 2015from June 14, 2014, to November 15, 2014. Two patients in
the DEX group were eliminated due to conversions to open
gastrectomy or concurrent cholecystectomy. The remaining
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.
90 patients successfully completed the study without any
complications. Patient characteristics were comparable between
the control and the DEX groups. The durations of anesthesia
and CO2 pneumoperitoneum were not significantly different
between groups (Table 1).
Postoperative Outcomes
The time to first flatus was earlier in the DEX group
compared with the control group (67.2 16.8 hours vs
79.9 15.9 hours, P< 0.001). There were no significant differ-
ences in the time to first diet intake (3.5 0.5 days vs 3.6
0.6 days, P¼ 0.28) and the length of postoperative hospital stay
(5.8 2.0 days vs 6.8 3.3 days, P¼ 0.10) between groups.
However, the length of postoperative hospital stay among
patients without surgical complications was significantly
shorter in the DEX group compared with the control group
(5.4 0.7 days vs 5.8 1.1 days, P¼ 0.04) (Table 2).
Vital Signs, ETCO2, BIS Scores, and Anesthetic
Concentrations
Significant differences in MBP and HR were found
between groups using the linear mixed model analysis
(P¼ 0.002 and P< 0.001, respectively). Post hoc analyses with
the Bonferroni correction revealed that MBP was significantly
lower in the DEX group than in the control group at T3, T4, and
T5. HR was significantly lower in the DEX group at T2, T3, T4,
and T5. ETCO2, BIS, and end-tidal desflurane concentrations
were similar between groups throughout all time points (Table
3). However, the concentration of remifentanil during surgery
was significantly lower in the DEX group compared with the
control group (0.03 0.02mg/kg/min vs 0.07 0.02mg/kg/
min, P< 0.001).
HR Variability
The LF power, HF power, and LF/HF ratio were compar-
Medicine  Volume 94, Number 24, June 2015able between groups at T1. In the control group, LF powers were
significantly increased at T2, T3, T4, and T5, as compared with
that at T1 (P< 0.05 for all comparisons). However, no increases
TABLE 1. Patient Characteristics and Intraoperative Variables
DEX
Age, y 55
Male/female
BMI, kg/m2 23
ASA class II/III
Diabetes mellitus with oral hypoglycemic agents
Hypertension
b-Adrenergic antagonists
RAAS inhibitors
Calcium channel blockers
Diuretics
Duration, anesthesia, min 185
Duration, pneumoperitoneum, min 122
Fluid intake, mL 1212
Urine output, mL 112
Blood loss, mL 58
Values are numbers or meanSD. ASA¼American Society of An
RAAS¼Renin-angiotensin-aldosteron system, SD¼ standard deviation.
MeanSD of this variable was calculated in patients without surgical
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.in LF power were observed in the DEX group. HF powers were
comparable at all time points in both groups. The LF/HF ratios
in the control group were significantly increased at T2, T3, T4,
and T5, as compared with that at T1 (P< 0.05 for all compari-
sons). In contrast, no increases in LF/HF ratios were observed in
the DEX group. In addition, the LF/HF ratios in the DEX group
were significantly lower than those in the control group at T2,
T3, T4, and T5 (P< 0.05 for all comparisons) (Figure 1).
Pain
NRS pain scores (3.8 1.3 vs 4.7 1.1, P¼ 0.001) and
the number of patients requiring additional fentanyl (23/44 vs
36/46, P¼ 0.009) in the PACU was significantly lower in the
DEX group vs control group. However, pain scores and the
number of patients requiring ‘‘rescue’’ analgesics during the
later postoperative time points (1–6, 6–24, and 24–48 hours)
were not different between groups (Table 4).
DISCUSSION
The intraoperative administration of DEX during laparo-
scopic gastrectomy facilitated the early recovery of bowel
function. It significantly shortened the time to first flatus and
reduced the length of postoperative hospital stay. In addition,
DEX reduced pain and the requirement for additional opioids
during the early postoperative periods. These results might
be attributed to the ability of DEX to attenuate sympathetic
hyperactivation and provide analgesia.
Pathogenesis of Postoperative Ileus:
Sympathetic Activation
Postoperative ileus is a major contributor to postoperative
morbidity and prolonged convalescence or hospital stay after
major abdominal surgery. The pathophysiology of postopera-
tive ileus is complex and involves many factors, including
Dexmedetomidine Reduces the Postoperative Ileussurgical trauma, activation of inhibitory sympathetic reflexes,
and induction of local and systemic inflammatory mediators.1 In
comparison with open surgery, laparoscopic gastrectomy has
(n¼ 44) Control (n¼ 46) P
.1 9.0 55.4 11.0 0.90
23/21 26/20 0.69
.1 2.6 23.2 2.6 0.81
12/2 15/1 0.73
5 5 0.94
8 10 0.67
1 1 0.98
6 8 0.62
7 6 0.70
0 3 0.09
.5 58.9 206.1 54.2 0.09
.7 48.2 141.5 46.5 0.06
.5 453.9 1335.4 520.7 0.24
.9 97.4 137.5 83.4 0.20
.2 68.4 92.9 95.1 0.05
esthesiologists, BMI¼ body mass index, DEX¼ dexmedetomidine,
complications.
www.md-journal.com | 3
TABLE 2. Postoperative Outcomes
DEX (n¼ 44) Control (n¼ 46) P
Time to first flatus, h 67.2 16.8 79.9 15.9 <0.001
Time to soft diet, d 3.5 0.6 3.6 0.6 0.28
Postoperative hospital stay (including all patients), d 5.8 2.0 6.8 3.3 0.10
Postoperative hospital stay (including patients without complications

), d 5.4 0.7 5.8 1.1 0.04
Surgical complications 2 5 0.26
Intra-abdominal abscess 0 1
Anastomosis leakage 0 2
Wound infection 2 1
Omental infarction 0 1
Bleeding 0 0
Reoperation 0 0
stan
ical
Cho et al Medicine  Volume 94, Number 24, June 2015been reported to reduce surgical trauma and attenuate the
Values are numbers or meanSD. DEX¼ dexmedetomidine, SD¼
MeanSD of this variable was calculated in patients without surgimmune response, thus reducing the time to flatus and the time
to the resumption of a soft diet.4,13 However, the induction
of pneumoperitoneum and surgical stimuli for laparoscopic
TABLE 3. Vital Signs, ETCO2, BIS Scores, and Anesthetic Concen
Variables Time Points
Mean arterial pressure, mm Hg T0
T1
T2
T3
T4
T5
HR, bpm T0
T1
T2
T3
T4
T5
ETCO2, mm Hg T1
T2
T3
T4
T5
BIS Score T1
T2
T3
T4
T5
End-tidal desflurane concentration, vol% T1
T2
T3
T4
T5
Remifentanil concentration, mg/kg/min
Values are mean standard deviation. T0, baseline; T1, 10 minutes after in
after CO2 insufflation, T4, 2 hours after CO2 insufflation, T5, 10 minutes af
ETCO2¼ end-tidal CO2, HR¼ heart rate, MBP¼mean blood pressure.
P< 0.05 versus baseline value.
yP< 0.05 versus control.
4 | www.md-journal.comvisualization can cause sympathetic activation. Parasympa-
dard deviation.
complications.thetic stimulation increases gastrointestinal motility, whereas
sympathetic stimulation serves as the predominant inhibitory
impetus to the bowel. Pneumoperitoneum reduces venous return
trations
DEX (n¼ 44) Control (n¼ 46) PGroupTime
89.2 10.4 91.5 12.6 0.002
79.1 14.3 76.5 14.3
89.8 13.4 93.0 13.3
78.4 8.2,y 87.5 11.2
77.8 10.1,y 87.9 12.9
74.3 10.0y 79.7 12.4
76.3 15.0 72.2 11.5 0.001
74.8 13.6 75.3 13.2
69.7 12.9,y 75.9 12.7
65.6 10.6,y 73.0 8.6
64.5 12.1,y 73.5 8.9
63.4 9.9,y 71.7 9.9
35.3 2.1 35.7 2.9 0.59
37.9 2.4 38.8 2.3
38.6 2.3 39.0 2.3
38.7 2.3 39.8 2.8
38.4 2.9 38.5 3.7
46.4 6.7 47.6 7.8 0.99
44.2 6.2 44.5 6.5
42.0 5.9 42.7 7.1
41.5 5.3 42.1 6.4
42.6 6.2 43.0 6.5
4.10 0.69 4.41 0.71 0.41
4.69 0.53 4.93 0.41
4.87 0.37 5.16 0.43
5.0 0.43 5.30 0.42
4.83 0.48 5.26 0.44
0.03 0.02 0.07 0.02 <0.001
duction and intubation, T2, 10 minutes after CO2 insufflation, T3, 1 hour
ter CO2 desufflation. BIS¼ bispectral index, DEX¼ dexmedetomidine,
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.
FIGURE 1. Changes in LF, HF, and the LF/HF ratio. Data are
expressed as mean standard error of the mean. T1, 10 minutes
after induction and intubation; T2, 10 minutes after CO2 insuffla-
Medicine  Volume 94, Number 24, June 2015and decreases cardiac output, which might provoke the baror-
eceptor reflex and sympathetic activation when combined with
the reversed Trendelenburg position.5,14 High-pressure pneu-
moperitoneum shows greater increases in sympathetic activity
than low-pressure pneumoperitoneum.15 In addition, CO2 pneu-
moperitoneum can induce hypercarbia, which directly and
indirectly stimulates the sympathetic nervous system by
increasing catecholamine levels.16 These sympathetic acti-
vation and inhibitory inputs have been demonstrated to be
factors in the development of postoperative ileus.17,18 Further-
more, the mechanism of sympathetic inhibition involves pre-
venting the release of acetylcholine, which is essential for
intestinal peristalsis, from excitatory fibers that are located in
the myenteric plexus.19
Previous Efforts to Attenuate Sympathetic
tion; T3, 1 hour after CO2 insufflation; T4, 2 hours after CO2
insufflation; T5, 10 minutes after CO2 desufflation. P<0.05 versus
baseline; yP<0.05versus control group.DEX¼dexmedetomidine,
HF¼high frequency, LF¼ low frequency.Activation
In an effort to reduce ileus, epidural anesthesia or the
administration of adrenoblocking agents has been used for
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.sympathetic blockade. Dihydroergotamine, which acts as a
sympatholytic agent in the gastrointestinal tract, reduces the
time to first bowel movement and increases bowel movements,
as determined via electromyography.7 Epidural blockade has
been proven to improve postoperative ileus, and its effect may
be associated with the blockade of afferent and efferent inhibi-
tory reflexes, as well as efferent sympathetic blockade.8 How-
ever, conflicting results regarding the duration of blockade,
drug administration, and level of blockade have been reported.
To this date, the administration of adrenoblocking agents or
parasympathetic agonists has not effectively reduced postopera-
tive ileus.
DEX: Sympatholytic Effects
DEX is a highly selective a2 adrenoceptor agonist that
has sympatholytic and analgesic effects. It acts on central
a2 adrenoceptors to reduce sympathetic tone and decrease
catecholamine levels.20 In addition, a2 adrenoceptor agonists
have been reported to induce nitric oxide-dependent vasore-
laxation that is mediated by endothelial a2 adrenoceptor acti-
vation.21 The ability of DEX to attenuate sympathetic activation
when used as a sedative or adjunct to general anesthesia has
been proven by measuring HRV.22,23 The spectral analysis of
HRV is widely used as a noninvasive method to assess cardiac
sympathetic and parasympathetic nervous system functions.24
In this study, during operations, the LF/HF ratio was used to
measure the balance between sympathetic and parasympathetic
tones in the ANS and was significantly increased in the control
group compared with baseline values. This represented sym-
pathetic hyperactivation. In contrast, the LF/HF ratio in the
DEX group was maintained at baseline levels during operations.
This suggests that DEX attenuates pneumoperitoneum- and
surgical stress-induced sympathetic activation. These findings
are consistent with the results of previous studies that investi-
gated the effects of DEX on autonomic responses during
stressful events. DEX has been shown to blunt the sympathetic
effect of sweating and attenuate the shivering-induced increase
in blood pressure and catecholamine release.22 It also
suppresses sympathetic hyperactivation during endotracheal
intubation.23
However, DEX has the potential to cause hypotension due
to systemic vasodilation via sympatholytic actions.25 It usually
elicits a biphasic hemodynamic response with an initial increase
in blood pressure and reflex bradycardia, followed by a sub-
sequent return to baseline after stabilization.26 Patients in the
DEX group had low blood pressures and HR, which may be due
to the sympatholytic effect of DEX. However, the chosen dose
in this study trial (0.4mg/kg/h) appeared to be safe, as blood
pressures and HR were maintained within 25% of baseline
values. An increase in the relative risk of developing brady-
cardia and hypotension (requiring treatment) was reported only
after administering a loading dose and maintenance dose of
>0.7mg/kg/h DEX in critically ill patients.27
DEX: Analgesic and Opioid-Sparing Effects
Adequate pain relief can contribute to the reduction of
postoperative ileus by allowing the patients to be mobilized
earlier. Therefore, enteral feeding can be instituted. Although
opioids are preferred for postoperative pain control, they are
notorious for effects on inhibiting gastrointestinal motility and
Dexmedetomidine Reduces the Postoperative Ileusaggravating postoperative ileus.28,29 In this study, the intrao-
perative use of DEX reduced opioid consumption during
surgery and the requirement of rescue fentanyl during the
www.md-journal.com | 5
TABLE 4. Pain Scores and Additional Analgesic Requirements
DEX (n¼ 44) Control (n¼ 46) P
Pain score
In PACU 3.8 1.3 4.7 1.1 0.001
Postop 1–6 h 4.5 1.9 5.0 1.9 0.17
Postop 6–24 h 4.1 1.9 3.7 1.6 0.24
Postop 24–48 h 4.5 1.8 4.3 2.0 0.62
Analgesic drugs
In PACU
Fentanyl, mg (n)

60.9 21.1 (23) 68.1 25.1 (36) 0.26 (0.009)
Pethidine, mg (n)

25 (1) 25 (5) >0.99 (0.10)
Postop 1–6 h (pethidine, mg) (n)

30.8 11.0 (13) 31.3 11.1 (20) 0.90 (0.19)
Postop 6–24 h (pethidine, mg) (n)

40.9 20.2 (11) 43.8 25.9 (8) 0.79 (0.43)
Postop 24–48 h (pethidine, mg) (n)

35.5 15.2 (19) 40.8 19.0 (19) 0.35 (0.75)
, a
osto
Cho et al Medicine  Volume 94, Number 24, June 2015postoperative 1-hour period. The DEX group had lower pain
scores, and less patients required rescue analgesics (fentanyl) in
the PACU. Previous studies also reported a reduction in opioid
requirements as well as decreased postoperative pain30,31 and
catheter-related bladder discomfort32 after intraoperative DEX
administration. The opioid-sparing effects of DEX may help to
reduce the opioid-induced inhibition of gastrointestinal moti-
lity. The failure of DEX to produce a sustained opioid-sparing
effect during the later postoperative period in our studymight be
related to its short elimination half-life of 2 hours. Because the
time course of the stress response to surgery continues beyond
the operative period, intraoperative DEX administration may
only modify the stress response for a relatively short period of
time. The continuous infusion of DEX during postoperative
periods is likely to result in better analgesia and earlier recovery
of bowel function. Therefore, further research on the adminis-
tration of DEX during perioperative periods is warranted.
LIMITATIONS
The mechanisms by which DEX improves bowel recovery
may involve intraoperative sympatholysis, which reduces ileus
by attenuating sympathetic inhibitory impetus to the bowel, and
the reduction of systemic opioids, which induces ileus by activat-
ing m-receptors in the gastrointestinal tract. Both mechanisms
may contribute to the reduction of ileus, although the impact of
eachmechanismon the return of bowelmovement is unknown. In
addition, the durations of anesthesia andpneumoperitoneumwere
relatively shorter in the DEX group than in the control group,
although therewere no statistical differences between the groups.
There is a possibility that they might affect the postoperative
outcomes. Last, no statistically significant differences in the
length of postoperative hospital stay were observed between
groups when all patients were included in the analysis. We
believe that the benefits of DEX could not have overcome any
delays in recovery that were caused by surgical complications.
However, when patients with major surgical complications were
excluded from the analysis, the length of postoperative hospital
stay was significantly reduced in the DEX group. Further studies
are needed to investigate this finding.
Values are numbers or mean standard deviation. Pain score
DEX¼ dexmedetomidine, PACU¼ postanesthesia care unit, postop¼ p
Number of patients requiring analgesic drugs.CONCLUSION
The administration of DEX during laparoscopic gastrect-
omy facilitated the early recovery of bowel function after
6 | www.md-journal.comsurgery. Our findings suggest that DEX can maintain autonomic
balance by attenuating the pneumoperitoneum- and surgery-
induced hyperactivation of the sympathetic nervous system.
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